OpenAI said via X: “We worked with @Ginkgo to connect GPT-5 to an autonomous lab, so it could propose experiments, run them at scale, learn from the results, and decide what to try next. That closed loop brought protein production cost down by 40%.” Shares of Ginkgo are up 3% to $8.50 following the post.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNA:
- Ginkgo Bioworks jumps after OpenAI comment on working together
- Private Markets: Anthropic raising $10B at $350B valuation
- Ginkgo Bioworks price target lowered to $12 from $14 at TD Cowen
- Ginkgo Bioworks price target lowered to $12 from $142 at TD Cowen
- Ginkgo Bioworks realigns leadership, shifts COO responsibilities